Publications by authors named "Mathilde Giroud"
Bull Cancer
September 2013
Article Synopsis
- The study conducted at Grenoble University Hospital aimed to assess how frequently and in what contexts midazolam is used among hospitalized patients, while also evaluating doctors' views on the drug.
- Out of 1,323 patients, 44 (3.3%) received midazolam, primarily for managing symptoms like dyspnea, confusion, pain, and psychological suffering, with 82% of these patients having cancer.
- Physicians perceived midazolam mainly as a signal to stop active treatment and a potential cause of early death, indicating a misunderstanding of its use for sedation versus anxiety relief, highlighting the need for clearer guidelines.
